U.S. International Trade Commission Investigates Citric Acid Imports
Estimated reading time: 5–10 minutes
The United States International Trade Commission (USITC) has announced the scheduling of the final phase of investigations concerning imports of citric acid and certain citrate salts. These investigations aim to determine if these imported products are causing harm to the U.S. industry.
The investigations focus on imports from Canada, India, and China. The Commission will determine if these imports are subsidized by foreign governments or sold in the U.S. at less-than-fair-value.
Scope of the Investigation
The investigation covers citric acid, sodium citrate, and potassium citrate. They are included whether they are dry, in solution, or packaged. It covers all forms, sizes, and blends of these substances. Intermediate products, like calcium citrate, are also included.
Background Information
The investigations began after petitions were filed by Archer-Daniels-Midland Company, Cargill International, and Primary Products Ingredients Americas LLC. They are checking if imports from Canada sell at fair prices, and whether Canadian and Indian imports receive unfair subsidies.
Hearing Information
A hearing is scheduled for January 12, 2027, at 9:30 a.m. Those wishing to appear must notify by January 6, 2027. Some witnesses can appear via video if necessary. The hearing will help the Commission understand the issues better.
Participation and Written Submissions
Parties wishing to participate need to file entries of appearance 21 days before the hearing. They must submit evidence and arguments about the case. Prehearing briefs are due by January 5, 2027. Posthearing briefs are due by January 20, 2027.
The Commission will release information on February 2, 2027. Final comments from parties are due by February 4, 2027.
The Commission is conducting its investigation under the authority of title VII of the Tariff Act of 1930. Public interest and fair trade are at the core of these investigations.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
